Related-Party Transactions

3 Months Ended

Mar. 31, 2017

Related Party Transactions [Abstract]

Related-Party Transactions

Note 14. Related-Party Transactions

QIAGEN Agreement

There have been no significant modifications or financial events relating to the Company’s agreements with QIAGEN Manchester Limited or with QIAGEN North American Holdings, Inc. (“QNAH”) since disclosures made by the Company in its Annual Report on Form 10-K, filed with the SEC on March 23, 2017.

As disclosed previously, QNAH agreed to purchase up to an additional $2.0 million of the Company’s common stock (subject to any applicable limitations under the rules of the NASDAQ Stock Market) upon the sale by the Company of at least $12.0 million of common or preferred stock in a financing transaction that occurs prior to May 16, 2017, or such other mutually agreeable date (a “Qualified Financing”). The price per share payable by QNAH in a second tranche closing will be equal to the price per share at which shares are sold in a Qualified Financing.